Fil d'Ariane
ComparEuEtdsWeb
QUESTION | |
---|---|
09. Should education, monitoring, and emotional behavioural techniques led by peers vs. usual care be used for adult patients living with heart failure? | |
Population | adult patients living with heart failure |
Intervention | Monitoring and emotional-based behavioural techniques lead by peers See more |
Comparison | Usual Care |
Main outcomes | Mortality; Heart failure Readmissions |
Setting | European Union, outpatient care |
Perspective | Clinical recommendation- Population perspective |
Background | Heart failure (HF), a complex clinical syndrome, is considered a global pandemic with an increasing overall incidence and prevalence due to ageing of population (Savarese G et al., 2017). HF clinical practice guideline self-management strategies are recommended to increase quality of life and to reduce the risk of HF hospitalization and mortality. However, there are still gaps in the evidence especially regarding the comparative effectiveness and cost-effectiveness of the strategies, due to variations in study locations and time of occurrence and to suboptimal reporting of patient-relevant outcomes (ESC 2021, Jonkman NH et al., 2016, Takeda A et al., 2019). |
Conflict of interest |
This work was supported by the EU Horizon 2020 research and innovation programme (grant agreement no. 754936). The funder had no role in developing the protocol or obtaining the results for this study. |
ASSESSMENT | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Priority of problem Is the problem a priority? |
||||||||||||||||||||||
JUDGEMENT | RESEARCH EVIDENCE | |||||||||||||||||||||
|
Heart failure (HF), a complex clinical syndrome, is considered a global pandemic with an increasing overall incidence and prevalence due to ageing of population (Savarese G et al., 2017). HF clinical practice guideline self-management strategies are recommended to increase quality of life and to reduce the risk of HF hospitalization and mortality. However, there are still gaps in the evidence especially regarding the comparative effectiveness and cost-effectiveness of the strategies, due to variations in study locations and time of occurrence and to suboptimal reporting of patient-relevant outcomes (ESC 2021, Jonkman NH et al., 2016, Takeda A et al., 2019). |
|||||||||||||||||||||
Desirable Effects How substantial are the desirable anticipated effects? |
||||||||||||||||||||||
JUDGEMENT | RESEARCH EVIDENCE | |||||||||||||||||||||
|
View summary of findings of network meta-analysis
View summary of findings of component network meta-analysis |
|||||||||||||||||||||
ADDITIONAL CONSIDERATIONS | ||||||||||||||||||||||
The guideline panel judged the desirable effects as large.
No data available for the rest of critical/important outcomes.
Proportion of direct evidence contributing to the final NMA estimate per outcome: Heart Failure Readmission: 100% Mortality (all causes) 100%
Component Network Meta-analysis: - Mortality: the components with larger effects are education (E), emotional-based behavioural techniques (EB) and delivered by peers (P) -Heart failure readmissions: the components with larger effects are education (E), monitoring techniques (MT), and emotional-based behavioural techniques (EB)
Studies that include this SMI: Sales-2014 - Dietary and pharmacologic education by a trained volunteer - 1 face-to-face session, 5 phone calls; all individual - Duration 30 days - Expected patient (or carer) self-management behaviours: o Lifestyle related behaviours § Eating behaviours § Doing physical activity o Clinical management § Condition-specific behaviours § Self-monitoring § Medication use and adherence § Early recognition of symptoms § Asking for professional help or emergency care when needed
Modeling estimations for long term consequences We used the COMPAR-EU model developed for the cost-effectiveness analysis to also inform about long-term health outcomes. Decision analysis models estimates provide valuable information for outcomes when empirical evidence is not available or is unfeasible (Trikalinos TA, 2009). The following events were estimated over a lifetime and informed by the effect of each SMIs over BMI from the NMA (see below). We suggest cautious interpretation as the certainty of the evidence for those input parameters was low to very low across comparisons. - Life-Years (LY): 85 days of additional life per person - Years with diabetes: 179 fewer days per person - Quality-Adjusted Life Years (QALY): 107 days of additional life equivalent to full health per person (undiscounted) - Diabetes mellitus: 19 fewer events per 1,000 persons - Myocardial infarction: 7 fewer events per 1,000 persons - Stroke: 8 fewer events per 1,000 persons |
||||||||||||||||||||||
Undesirable Effects How substantial are the undesirable anticipated effects? |
||||||||||||||||||||||
JUDGEMENT | RESEARCH EVIDENCE | |||||||||||||||||||||
|
View summary of findings of network meta-analysis
There are no undesirable observed effects. |
|||||||||||||||||||||
ADDITIONAL CONSIDERATIONS | ||||||||||||||||||||||
The guideline panel judged the undesirable effects as trivial or marginal. |
||||||||||||||||||||||
Certainty of the evidence What is the overall certainty of the evidence of effects? |
||||||||||||||||||||||
JUDGEMENT | RESEARCH EVIDENCE | |||||||||||||||||||||
|
||||||||||||||||||||||
ADDITIONAL CONSIDERATIONS | ||||||||||||||||||||||
The guideline panel has judged the certainty of the evidence as very low.
Certainty of the evidence was downgraded due to heterogeneity (of interventions and severity of disease), risk of bias, and imprecision. |
||||||||||||||||||||||
Values Is there important uncertainty about or variability in how much people value the main outcomes? |
||||||||||||||||||||||
JUDGEMENT | RESEARCH EVIDENCE | |||||||||||||||||||||
|
An overview of systematic reviews provided information about how patients value several of the outcomes of interest (critical/important) included in this clinical question:
References
|
|||||||||||||||||||||
ADDITIONAL CONSIDERATIONS | ||||||||||||||||||||||
The guideline panel judged that there is probably no important uncertainty or variabilty y on how patients value the main outcomes.
The panel agreed that there is some variability on how patients value the outcomes, since preferences will vary based on patients' particular starting point, and their disease progression. The panel also noted, that the variability on how patients value the main outcomes, could also depend on the intensity of monitoring. |
||||||||||||||||||||||
Balance of effects Does the balance between desirable and undesirable effects favor the intervention or the comparison? |
||||||||||||||||||||||
JUDGEMENT | RESEARCH EVIDENCE | |||||||||||||||||||||
|
||||||||||||||||||||||
ADDITIONAL CONSIDERATIONS | ||||||||||||||||||||||
The guideline panel judged that the balance of effects probably favours the intervention. This is due to the large desirable effects, the trivial undesirable effects, the probably no important uncertainty and variability on how patients value outcomes, as well as the very low certainty of evidence of effects. |
||||||||||||||||||||||
Resources required How large are the resource requirements (costs)? |
||||||||||||||||||||||
JUDGEMENT | RESEARCH EVIDENCE | |||||||||||||||||||||
|
Estimated costs for the intervention across all types of self-management interventions (SMIs), as described in the included studies of the network meta-analysis, were on average 794 euros per patient, with a range from 85 to 2,045 euros. Please note that this average/range estimate has been based on ten cost estimates of SMIs for HF reported in publications.
Furthermore, most of the SMIs were an element of a management program, which means that the other costs of the management program are not taken into account in the intervention costs. Model analyses showed that over lifetime the total costs (without cost of the intervention) for the SMI were 1,031 euros higher compared to usual care. This cost increase was mainly the result of an increased life-expectancy with additional costs in the life-years gained.
References Trikalinos TA, Siebert U, Lau J. Decision-analytic modeling to evaluate benefits and harms of medical tests: uses and limitations. Med Decis Making. 2009 Sep-Oct;29(5):E22-9. Girling A, Lilford R, Cole A, Young T. Headroom approach to device development: current and future directions. Int J Technol Assess Health Care. 2015 Jan;31(5):331-8. |
|||||||||||||||||||||
ADDITIONAL CONSIDERATIONS | ||||||||||||||||||||||
Despite the scarcity of data in available publications, and the important variability in the characteristics of self-monitoring interventions the panel considered that the resources required varies for this SMI.
Resource use and costing data for SMIs should be interpreted with caution. We could not provide cost for any specific type of SMI intervention, because in many publications detailed information needed to estimate the intervention cost was missing (for example number of sessions, average group size or duration of sessions). As an alternative, we searched for intervention cost estimates as presented by the authors of publications and used the average value as an estimate of the average costs of SMI programs for HF in general. |
||||||||||||||||||||||
Certainty of evidence of required resources What is the certainty of the evidence of resource requirements (costs)? |
||||||||||||||||||||||
JUDGEMENT | RESEARCH EVIDENCE | |||||||||||||||||||||
|
||||||||||||||||||||||
ADDITIONAL CONSIDERATIONS | ||||||||||||||||||||||
|
||||||||||||||||||||||
Cost-effectiveness Does the cost-effectiveness of the intervention favor the intervention or the comparison? |
||||||||||||||||||||||
JUDGEMENT | RESEARCH EVIDENCE | |||||||||||||||||||||
|
The table below shows the cost-effectiveness results for the SMI intervention. Costs and QALYs in this analysis were discounted at 3.5% annual rate.
NA: not applicable; QALY: quality adjusted life years; ICER: incremental cost-effectiveness ratio Explanations
|
|||||||||||||||||||||
ADDITIONAL CONSIDERATIONS | ||||||||||||||||||||||
The guideline panel judged that the cost-effectiveness does not favor either the intervention or the comparison.
There is only a very low possibility that this specific SMI can be cost-effective, but this depends on the intervention costs of the particular intervention and the threshold used. The intervention is never cost-effective with a threshold value of 20,000 euro/QALY and the headroom is 190 euro maximum when a threshold value of 50,000 euro/QALY is used. Because the average cost of SMI for HF in the literature (793euro, range: 65 to 2,045) is higher than the headroom estimate for 50,000 euro/QALY, the probability that the intervention is cost-effective at 50,000/QALY is very low.
|
||||||||||||||||||||||
Equity What would be the impact on health equity? |
||||||||||||||||||||||
JUDGEMENT | RESEARCH EVIDENCE | |||||||||||||||||||||
|
||||||||||||||||||||||
ADDITIONAL CONSIDERATIONS | ||||||||||||||||||||||
The panel agreed that the impact on health equity varies, due to the variability across European countries on the levels of health literacy and socioeconomic status. Equity may be affected by geography and accessibility.
If implemented, tailored to culture and health literacy, it may increase equity. |
||||||||||||||||||||||
Acceptability Is the intervention acceptable to key stakeholders? |
||||||||||||||||||||||
JUDGEMENT | RESEARCH EVIDENCE | |||||||||||||||||||||
|
The information below has been obtained through an overview of systematic reviews of contextual factors, as well as a scoping review and one overview of systematic reviews of values and preferences. It also includes considerations from a Delphi study that was conducted in COMPAR-EU that included the most important contextual factors for the implementation of components (e.g. groups, peers) of self-management interventions according to stakeholders.
References
|
|||||||||||||||||||||
ADDITIONAL CONSIDERATIONS | ||||||||||||||||||||||
The guideline panel has judged that this type of SMI is probably acceptable to key stakeholders.
Patients/caregivers: overall acceptable but may vary since it could be influenced by setting, accessibility, tailoring, and other factors.
Healthcare perspective: It could be time and resource consuming.
Healthcare payers’ perspective: Overall acceptable.
Studies' Interventions Sales-2014 - Dietary and pharmacologic education by a trained volunteer - 1 face-to-face session, 5 phone calls; all individual - Duration 30 days - Expected patient (or carer) self-management behaviours: o Lifestyle related behaviours § Eating behaviours § Doing physical activity o Clinical management § Condition-specific behaviours § Self-monitoring § Medication use and adherence § Early recognition of symptoms § Asking for professional help or emergency care when needed |
||||||||||||||||||||||
Feasibility Is the intervention feasible to implement? |
||||||||||||||||||||||
JUDGEMENT | RESEARCH EVIDENCE | |||||||||||||||||||||
|
The information below has been obtained through an overview of systematic reviews of contextual factors, as well as a scoping review and one overview of systematic reviews of values and preferences. It also includes considerations from a Delphi study that was conducted in COMPAR-EU that included the most important contextual factors for the implementation of components (e.g. groups,peers) of self-management interventions according to stakeholders.
References
|
|||||||||||||||||||||
ADDITIONAL CONSIDERATIONS | ||||||||||||||||||||||
The guideline panel judged that the feasibility of implementing this type of SMI varies.
Implementation may be difficult, depending on the context and the use of specific devices for monitoring, for example, online feedback could be more complicated to obtain in certain contexts. and may depend on resources availablity.
Limited human resources, healthcare system coordination and transport services may complicate the implementation of this SMI.
Usually, duration of follow-up was not provided in the studies.
Studies' Interventions Sales-2014 - Dietary and pharmacologic education by a trained volunteer - 1 face-to-face session, 5 phone calls; all individual - Duration 30 days - Expected patient (or carer) self-management behaviours: o Lifestyle related behaviours § Eating behaviours § Doing physical activity o Clinical management § Condition-specific behaviours § Self-monitoring § Medication use and adherence § Early recognition of symptoms § Asking for professional help or emergency care when needed
|
TYPE OF RECOMMENDATION | ||||
---|---|---|---|---|
Strong recommendation against the intervention | Conditional recommendation against the intervention | Conditional recommendation for either the intervention or the comparison | Conditional recommendation for the intervention | Strong recommendation for the intervention |
CONCLUSIONS |
---|
Recommendation |
For patients with heart failure, the COMPAR-EU heart failure panel, suggests in favour of the use of Education, monitoring, and emotional (coaching, motivation, and stress management) behavioural techniques led by peers with or without professionals rather than usual care (conditional, very low certainty of the evidence about the effects). |
Justification |
The COMPAR-EU heart failure panel made a conditional recommendation in favour of, Education, monitoring, and emotional (coaching, motivation, and stress management) behavioural techniques led by peers with or without professionals, rather than usual care, given a balance that probably favours the intervention (very low quality evidence of effects), the cost-effectiveness evaluation that favours either the intervention or usual care, and an intervention that is probably acceptable for main stakeholders. |
Subgroup considerations |
Effect of the intervention may differ according to the intensity and duration of the intervention |
Implementation considerations |
When implementing SMI in general, the most important contextual factors to keep in mind are:
When implementing Education the most important contextual factors to keep in mind are:
When implementing monitoring techniques, the most important contextual factors to keep in mind are:
When implementing Emotional-based behavioural techniques, the most important contextual factors to keep in mind are:
When implementing SMI delivered by peers the most important contextual factors to keep in mind are:
Other contextual factor: to have education and continuous support of peer providers. |
Monitoring and evaluation |
Research priorities |
- Future studies should measure patient important outcomes, both critical and important (list below), have adequate sample size and follow-up, including after the intervention is finished. - Future studies should address also preferences and values of patients in relation to their self management, cost effectiveness and sub-categories of self-monitoring interventions. - Future studies should describe in detail the aspects of the intervention and evalute the long term effectiveness.
Critical outcomes
|
REFERENCES SUMMARY |
---|
Summary of findings of network meta-analysis
Isof web COMPAR-EU
Summary of findings of component network meta-analysis
COMPONENT NETWORK META-ANALYSIS (sensitivity analysis)
Outcome |
| Components’ effect (95% Confidence Interval) | CNMA effect (95% Confidence Interval) | |||
E | MT | EB | P | |||
Mortality | 0,95 (0,79 to 1,14) | 1,02 (0,84 to 1,22) | 0,85 (0,70 to 1,02) | 0,29 (0,12 to 0,71) | 0,67 (0,28 to 1,54) | |
Heart failure Readmissions | 0,74 (0,58 to 0,94) | 0,96 (0,78 to 1,19) | 0,79 (0,59 to 1,08) | 1,18 (0,52 to 2,69) | 0,24 (0,09 to 0,57) |
Components' definition:
E: Education; MT Monitoring techniques; EB emotional-based behavioural techniques; P peers
Components
Education (E)
Education (E)
Sharing information. This form of support consists in sharing of information about self-management topics like coping with symptoms, diet, exercise, medication, information about what other people are doing, and information about the disease itself, or about any other relevant aspects that could lead to improved self-management, and ultimately better health. This information can be told or distributed in printed materials like a folder or workbook, or via website or DVD.
Examples: Educational session on healthy eating for people with obesity, provision of a printed leaflet on the importance of foot care in diabetes, or a link to a website with information on chronic obstructive pulmonary disease care.
Monitoring techniques (MT)
Monitoring techniques (MT)
Self-monitoring training and feedback. Training and encouraging people to recognize, monitor, and record behaviours, symptoms, or clinical data. This process may include regular feedback from a clinician, or a synopsis of information registered in a digital tool to encourage you to continue monitoring your illness and behaviours.
Example: Showing a patient how to record blood sugar levels, physical activity, or pain.
Emotional-based change techniques (EB)
Emotional-based change techniques (EB)
There are different emotional-based behavioural change techniques:
Stress and/or emotional management. This technique consists in helping you to understand the role of stress and emotions and teaching them to use different coping strategies to manage, for example, stress and painful emotions caused by your disease.
Examples: Mindfulness, exercise, stretching, listening to music, deep breathing, or meditation.
Coaching and motivational interviewing. This kind of support helps you to change behaviours by looking what’s important to you, and then offering support, taking into account your needs and preferences. One provider (healthcare professional, peer or lay person) is usually your coach. Motivational interviewing and counselling are included, as well as collaborative conversations with a practitioner, helping with motivation and commitment, minimizing resistance, and resolve ambivalence to change.
Examples: coaching sessions led by a nurse to ease the transition from hospital to home, or rehabilitation programs using coaching methods.
Peers (P)
Peers (P)
The intervention is carried out by peers, people who have experienced living with the same disease or by lay people living in your community. Rather than involving just health professionals or educators, the intervention involves one or more peers who take on a role in the teaching and/or providing information about the intervention.
Examples: Training and teaching activities provided by peers to guide people with a related health care concern, to adopt a new behaviour that would facilitate healthy outcomes.
Individual sessions
A single person receives the self-management support. Examples: self-guided actions (without the participation of any other person) during a clinical visit or within the context of a support or educational session
Face-to-face
Self-management support delivered in a face-to-face encounter between the providers and patients and/or caregivers.